Human neural progenitors from different foetal forebrain regions remyelinate the adult mouse spinal cord
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Improving oligodendroglial differentiation from human foetal neural progenitor cells remains a primordial issue to accomplish successful cell-based therapies in myelin diseases. Here, we combined in situ, in vitro and in vivo approaches to assess the oligodendrogenic potential of different human foetal forebrain regions during the first trimester of gestation. We show for the first time that the initial wave of oligodendrocyte progenitor emergence in the ventral telencephalon onsets as early as 7.5 weeks into gestation. Interestingly, in vitro, isolation of ganglionic eminences yielded oligodendrocyte progenitor-enriched cultures, as compared with cortex and thalamus. Most importantly, single injection of human neural progenitors into rodent models of focal gliotoxic demyelination revealed the great capacity of these cells to survive, extensively migrate and successfully remyelinate the spinal cord, irrespective of their origin. Thus, our study brings novel insights into the biology of early human foetal neural progenitor cells and offers new support for the development of cellular therapeutics for myelin disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544
Kessaris, N., Fogarty, M., Iannarelli, P., Grist, M., Wegner, M., & Richardson, W. D. (2006) · Nature Neuroscience · doi:10.1038/nn1620 · Cited by 1,195 · cited 2×
“Each of these waves give rise to distinct oligodendrocyte progenitor cell populations that can be distinguished from one another by the initial expression of homeobox genes that sign their territorial origins (Kessaris et al., 2006).”
Background(2009) · doi:10.1007/978-3-540-29678-2 · Cited by 900
Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity
Nishiyama, A., Komitova, M., Suzuki, R., & Zhu, X. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2495 · Cited by 865 · cited 1×
“It is now well-established that the adult parenchyma contains proliferating glial progenitors (Nishiyama et al., 2009) that participate in remyelination when demyelination occurs (Franklin and ffrenchConstant, 2008).”
BackgroundProliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord
Horner, P. J., Power, A. E., Kempermann, G., Kuhn, H. G., Palmer, T. D., Winkler, J., Thal, L. J., & Gage, F. H. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-06-02218.2000 · Cited by 777 · cited 2×
“Under normal conditions, the majority of these proliferating cells eventually die, while some ( 5%) give rise to mature oligodendrocytes (Horner et al., 2000), thereby pleading in favour of a natural, albeit slow, turnover of myelinating oligodendrocytes in the adult CNS (Lasiene et al.”
BackgroundWindrem, M. S., Nunes, M. C., Rashbaum, W. K., Schwartz, T. H., Goodman, R. A., McKhann, G., Roy, N. S., & Goldman, S. A. (2004) · Nature Medicine · doi:10.1038/nm974 · Cited by 451 · cited 2×
“One of these consisted of selecting early glial progenitor cells from human tissue, based on their expression of membrane markers (Roy et al., 1999; Windrem et al., 2004, 2008).”
BackgroundLoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10369 · Cited by 388
Richardson, W. D., Kessaris, N., & Pringle, N. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1826 · Cited by 385 · cited 5×
“Although the functional equivalence of oligodendrocytes emerging from different CNS regions during development remains an open issue (Richardson et al., 2006), we show that hNPCs isolated from different forebrain areas can replace oligodendrocytes lost in demyelinating diseases with equal efficiency.”
BackgroundInfluentialOligodendrocyte development and the onset of myelination in the human fetal brain
Jakovcevski, I. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.005.2009 · Cited by 323 · cited 2×
“However, until now, most of the developmental studies focusing on oligodendrocyte progenitor cell emergence in the human forebrain have been conducted either at very early stages of development when oligodendrocyte progenitor cells cannot yet be detected (Jakovcevski and Zecevic, 2005a), or on second trimester foetuse…”
BackgroundAge-related myelin dynamics revealed by increased oligodendrogenesis and short internodes
Lasiene, J., Matsui, A., Sawa, Y., Wong, F., & Horner, P. J. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00462.x · Cited by 111
Eftekharpour, E., Karimi-Abdolrezaee, S., Wang, J., El Beheiry, H., Morshead, C., & Fehlings, M. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0273-07.2007 · Cited by 110 · cited 2×
“, 2008), very few studies documented these features in the adult ‘shiverer’ CNS, at a time by which the pathology has already settled (Cummings et al., 2005; Eftekharpour et al., 2007).”
BackgroundLopresti, P. (2002) · Glia · doi:10.1002/glia.10035 · Cited by 33
Cited by
Myelin in the Central Nervous System: Structure, Function, and Pathology
Stadelmann, C., Timmler, S., Barrantes-Freer, A., & Simons, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00031.2018 · Cited by 728
Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614412114 · Cited by 257
Fard, M. K., van der Meer, F., Sánchez, P., Cantuti-Castelvetri, L., Mandad, S., Jäkel, S., Fornasiero, E. F., Schmitt, S., Ehrlich, M., Starost, L., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aam7816 · Cited by 249
De Feo, D., Merlini, A., Laterza, C., & Martino, G. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328352ec45 · Cited by 181
Stem cell derived oligodendrocytes to study myelin diseases
Chanoumidou, K., Mozafari, S., Baron‐Van Evercooren, A., & Kuhlmann, T. (2020) · Glia · doi:10.1002/glia.23733 · Cited by 62
“Data were presented as mean ± SEM (Buchet et al., 2011; Mozafari et al., 2015). immunodeficient shiverer host, differentiated 3–4 fold more into CC1 + oligodendrocytes and contributed 1.5 fold more to myelination of the dorsal column lesion compared to hfNPC, suggesting as previously demonstrated with fetal cells (Mar…”
BackgroundResultInfluential
Metadata
- Authors
- Buchet, D., Garcia, C., Deboux, C., Nait-Oumesmar, B., & Baron-Van Evercooren, A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03-31
- Volume
- 134
- Issue
- 4
- Pages
- 1168-1183
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2159914601
- Cited by
- 47
- References
- 12
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.